// App-Quantinova.ai

SUN-753 : Sglt-2 Inhibitors & Ketacidosis in Bariatric Patients: A Cases Series

Researchers

Presenter

  • Stephanie Dizon

Principal Investigators

  • Amel Arnaout

Medical Centers

  • University of Ottawa, Greely,Canada

  • University of Ottawa, Ottawa, ON, Canada

  • Univ of Ottawa, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Body mass index

Drug/Treatment

  • Canagliflozin

  • Liraglutide

  • Intranasal glucagon

  • Insulin glargine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved